Las plaquetas en la diabetes mellitus

Revista Cubana de Hematologia, Inmunologia y Hemoterapia

Volumn 17, Issue 1, 2001, Pages 19-24

  Quintana, Xiomara González ^a   Rodríguez, Miriam Notario ^a,b   Sabo, Armando Guzmán ^a,c  

^a INSTITUTO DE HEMATOLOGÍA E INMUNOLOGÍA   (Cuba)

^b Hospital Ángel Arturo Aballí

^c Clínica María Elisa Rodríguez del Rey Bocalandro   (United States)

Author keywords

Blood platelets disorders; Diabetes mellitus complications

Indexed keywords

EID: 52549084867     PISSN: 08640289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Shukla SD, Klachkat AP, Klachkat DM. Hipersensitivity of diabetes human platelet activity factor. Thromb Res 1992;66:239-46.
2. Tschoepe D, Roesen P, Schiwippent B, Grils FA. Platelets in diabetes: the role in the hemostatic regulation in atheroesclerosis. Semin Thromb Hemost 1993;19:122-8.
3. Méndez JD, Zarzoza E, Islas S, Guillén C, Gutiérrez G. Alteraciones sanguíneas y vasculares en la diabetes mellitus. Rev Iberoam Tromb Hemostasis 1996;9:43-50.
4. Diabetes epidemiology. Research International Mortality. Study Group International evaluation of cause-specific mortality and IDDM. Diabetes Care 1991;14:55-60.
5. Songer TJ, De Berry K, La Pati RE, Tuomilekto J. International comparisons of IDDM mortality. Diabetes Care 1992;15(Suppl 1):15-20.
6. Supla SD, Paul A, Klachkat DM. Hypersensitivity of diabetic human platelets to platelet activating factor. Trombos Res 1992;66:239-46.
7. Skyler TS. Complicaciones de la diabetes en los 90. En: Rull JA, Zorrilla E, Jadzensby MN, Santiago JV, eds. Diabetes mellitus. Complicaciones crónicas. México, DF: Interamericana, McGraw-Hill, 1992;43.
8. Frote A, Islas S, Venegas A, Castro G, López J, Rojas I. Complicaciones crónicas de la diabetes mellitus. Clasificación. En: Islas S, Lifshitz A, eds. Diabetes mellitus. México, DF: Interamericana, McGraw-Hill, 1993:156.
9. Méndez JD, Ramos RH. Modelos experimentales. En: Islas S, Lifshitz A, eds. Diabetes mellitus. México, DF: Interamerica, McGraw-Hill, 1993:303.
10. Acang N, Jalil FD. Hypercoagulation in diabetes mellitus. Southeast Asian J Trop Med Public Health 1993;24(Suppl 1):263-6.
11. Packhan MA, Mustard JF. The role of platelets in the development and complications of atheroesclerosis. Semin Hematol 1986;23:8-19.
12. Ceriello A, Marchi E, Barbanti M, Milani MR, Giuliana D, Quatraro A, et al. Non-enzimatic glycacion reduce heparen cofactor II antihrombin activity. Diabetelogía 1990;33:205-7.
13. Ceriello A, Cuatrano A, Marchi E, Barbanti M, Dello Russo P, Lefebrine P. The role of hyperglycemia induced alteration of AT-III and factor X activation in the thrombin hyperactivity of diabetes mellitus. Diabetes Med 1990;7:343-8.
14. Lorenzy M, Cagliena E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes 1991;40:653-9.
15. Kwan HC. Changes in blood coagulation platelets function and plasminogen-plasmin system in diabetes. Diabetes 1992;41(Suppl 2):32-5.
16. Martin JF, Booth RFG, Monzada S. Arterial wall hypoxia following thrombosis of the vasa-vasorum in an initial lesion in atheroesclerosis. Eur J Clin Invest 1991;21:355-9.
17. Orwoll ES, Orwoll RL. Hematologic abnormalities in patients with endocrinal and metabolic disorders. Hematol Oncol Clin North Am 1987;1:261-79.
18. th ed. CD-ROM, 1998:334.
19. Martin JF, Bath PM, BVW ML. Influence of platelet size on out come after myocardial infraction. Lancet 1991;338:1409-11.
20. Winocour PB. Platelet abnormalities in diabetes mellitus. Diabetes 1992;41(Suppl 2):56-63.
21. Winocour PD. Pathwayes responsible for platelet hypersensitivity in rats with diabetes. J Lab Clin Med 1986;107:154-8.
22. Muruganadam A, Romsa JG, Thibert RT. Glycated calmadulin from platelets as an index of glycemia control. Clin Chem 1993;39:815-9.
23. Betteridge J. Diabetes dyshpidemia. Am J Med 1994;96(Suppl GA):25 S-31 S.
24. Grupo de Estudios de Diabetes Mellitus. Hipertensión arterial e hipercolesterolemia. Perspect Diabetes 1996;1:8-9.
25. Tschöpe D, Rösen P, Krufman L, Schauseil S, Kiholl B, Osterman F, et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 1990;20:166-70.
26. Watanabe Y, Kawada N, Kobayaski B. Effect of insulin on murine megakaryopoiesis in a liquid culture system. Cell Struct Funct 1987;12:311-6.
27. Tscöpe D, Schwippert B, Schetten B, Kiesel U, Rothi P, Roesen P, et al. Increased GPIIb/IIIa expression and altered DNA-ploidy pattern in magakaryocy-tes of diabetes BB-rats. Eur J Clin Invest 1992;22:591-8.
28. Tsichöpe D, Osterman H, Hübinger A, Ziegler D, Wiefels K, Gries FA. Elinated platelet activation in type I diabetics with chronic complications under long term nean normoglycemic control. Haemostasis 1990;20:93-8.
29. Abrams CHS, Ellison N, Budzynski AZ, Shattil SJ. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry 1990;11:652-6.
30. Tschöpe D, Rösen P, Schivippent B, Keholl B, Schauseil S, Essen J, et al. Platelet analysis using flowcytometric procedure. Platelets 1990;1:127-33.
31. Tsichöpe D, Essen J, Schivippent B, Rösen P, Kehoel B, Nieuwenhuis HK, et al. Large platelets circutate in an activated state in diabetes mellitus. Semin Thromb Haemost 1991;17:433-9.
32. McEven PP. Propenties of GMP/140 an inducible granule membrane protein of platelets and endotheliem. Blood Cells 1990;16:73-83.
33. Newly DE, Wright RA, Ludlam CA, Iox KAA, Boon NA, Wibb DJ. An in vivo model of the assessment of acute fibrinolytic capacity of the endothelium. Thromb Hemostast 1977;78:1242-8.